医药制造行业成本粘性对企业绩效的影响研究

Research on the Impact of Cost Stickiness on the Performance of Pharmaceutical Manufacturing Industry

成本粘性打破了传统的成本习性理论,为企业的管理开辟了新的视角。选取2013—2019年A股医药制造业上市公司数据作为依据,采用多元回归的方法,并加入股权性质作为调节变量进一步探究成本粘性与企业绩效的关系。研究表明该行业普遍存在成本粘性,并且成本粘性和反成本粘性均对企业绩效有正向促进作用,同时股权性质对两者的关系起到了调节作用,非国有控股企业的成本粘性对企业绩效的影响较强,国有控股企业的成本粘性对企业绩效的影响较弱。

Cost stickiness breaks the traditional cost habit theory and provides a new perspective for enterprise management.Based on the data of A-share pharmaceutical manufacturing listed companies from 2013 to 2019,this paper uses multiple regression method and nature of equity as adjusting variables to further explore the relationship between cost stickiness and corporate performance.The research shows that cost stickiness generally exists in this industry,and both cost stickiness and anti cost stickiness have a positive role in promoting enterprise performance.At the same time,the nature of equity plays a regulatory role in the relationship between them.The cost stickiness of non-state-owned holding enterprises has a strong impact on enterprise performance,while the cost stickiness of state-owned holding enterprises has a weak impact on enterprise performance.The results of the study provide some reference for the cost management and enterprise development of the industry.